Surprising Prognosis for Normal ACS

St elevation acute coronary syndromes are typically caused by thrombotic obstruction of a coronary artery due to ruptured atherosclerosis plaque.

Sorpresivo pronóstico para los infartos con coronarias normales

However, there is a significant number of patients with similar clinical presentations but no evidence of obstructive coronary artery disease (CAD).


Read also: CTO in patients with acute myocardial infarction increases long term mortality.


In general, patients without obstructive CAD have better survival, but this might vary substantially depending on the underlying cause and risk factors.

 

The present study included 4793 consecutive patients undergoing ST elevation MI.  88% of these patients had obstructive CAD (≥50% stenosis), 6% had no obstructive CAD (1-49% stenosis) and 5% presented absolutely normal coronary arteries.

 

Patients without CAD were mostly young women with few risk factors. Follow up reached mean 2.6 years.


Read also: Primary angioplasty and multivessel lesions: how should we proceed?


Short term mortality (30 days) was lower both for patients with non-obstructive CAD (HR 0.49; p=0.0018) and for patients with normal coronary arteries (HR 0.31; p=0.021), compared to patients with obstructive CAD.

 

But surprisingly (and just the opposite of what was observed at 30 days) long term mortality with non-obstructive CAD resulted similar (HR 1.15; p=0.48), and for those with normal coronary arteries, it resulted significantly higher (HR 2.44; p<0.001) than that of patients with typical MI (even after adjusting by troponin level).

 

Cause of death was cardiovascular in 70% of cases with typical infarction, but in patients with non-obstructive CAD, it was only 38%, and 32% in patients with normal arteries.


Read also: Is Emergency Cardiac Surgery Necessary in TAVR?


In a population matched by sex and age, mortality resulted superior in patients with non-obstructive CAD.

 

Conclusion

Patients undergoing ST elevation MI that do not present significant obstruction to their coronary arteries have similar and even superior mortality than patients with typical MI. These data suggest that treating these patients involve far more than the routine angiography, and that it should include medication and close follow-up.

 

Original title: Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Reference: Hedvig Bille Andersson et al. Eur Heart J. 2018 Jan 7;39(2):102-110.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...